Rho kinase-mediated vasoconstriction in pulmonary hypertension

Advances in Experimental Medicine and Biology

Volumn 661, Issue , 2010, Pages 299-308

  McMurtry, Ivan F ^a   Abe, Kohtaro ^a,b   Ota, Hiroki ^a   Fagan, Karen A ^a   Oka, Masahiko ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Chronic hypoxia; Monocrotaline; Pulmonary hypertension; Pulmonary vascular remodeling; Pulmonary vasoconstriction; Rho kinase; RhoA

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; BLEOMYCIN; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; FASUDIL; G PROTEIN COUPLED RECEPTOR; INTEGRIN; MONOCROTALINE; MYOSIN ADENOSINE TRIPHOSPHATASE; NIFEDIPINE; NITRIC OXIDE; PROSTACYCLIN; PROTEIN TYROSINE KINASE; RHO KINASE; RHO KINASE INHIBITOR; ROSIGLITAZONE; SEMAXANIB; SEROTONIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN;

CONFERENCE PAPER; CYTOSKELETON; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; HYPOXIA; LUNG RESECTION; LUNG VASOCONSTRICTION; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ANIMAL; CYTOLOGY; GENETICS; LUNG; METABOLISM; MUSCLE CONTRACTION; PATHOLOGY; PHYSIOLOGY; REVIEW; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; VASOCONSTRICTION;

RATTUS;

ANIMALS; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; HUMANS; HYPERTENSION, PULMONARY; LUNG; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RHO-ASSOCIATED KINASES; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

EID: 77951239891     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-60761-500-2_19     Document Type: Conference Paper

References (60)

1. Pietra GG, Capron F, Stewart S et al (2004) Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43:25S-32S (Pubitemid 38759714)
2. Rich S (2009) The effects of vasodilators in pulmonary hypertension. Pulmonary vascular or peripheral vascular? Circ Heart Fail 2:145-150
3. Sitbon O, Humbert M, Jais X et al (2005) Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 111:3105-3111 (Pubitemid 40847788)
4. Rabinovitch M (2008) Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 118:2372-2379 (Pubitemid 351949764)
5. Oka M, Fagan KA, Jones PL, McMurtry IF (2008) Therapeutic potential of RhoA/Rho kinase inhibitors in pulmonary hypertension. Br J Pharmacol 155:444-454
6. Oka M, Homma N, McMurtry IF (2008) Rho kinase-mediated vasoconstriction in rat models of pulmonary hypertension. Methods Enzymol 439:191-204
7. Gunst SJ, Zhang W (2008) Actin cytoskeletal dynamics in smooth muscle: a new paradigm for the regulation of smooth muscle contraction. Am J Physiol Cell Physiol 295:C576-C587
8. Kim HR, Appel S, Vetterkind S, Gangopadhyay SS, Morgan KG (2008) Smooth muscle signalling pathways in health and disease. J Cell Mol Med 12:2165-2180
9. Ratz PH, Berg KM, Urban NH, Miner AS (2005) Regulation of smooth muscle calcium sensitivity: KCl as a calcium-sensitizing stimulus. Am J Physiol Cell Physiol 288:C769-C783 (Pubitemid 40395055)
10. Somlyo AP, Somlyo AV (2003) Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 83:1325-1358 (Pubitemid 37222274)
11. Tang DD, Anfinogenova Y (2008) Physiologic properties and regulation of the actin cytoskeleton in vascular smooth muscle. J Cardiovasc Pharmacol Ther 13:130-140 (Pubitemid 351704167)
12. Broughton BR, Walker BR, Resta TC (2008) Chronic hypoxia induces Rho kinase-dependent myogenic tone in small pulmonary arteries. Am J Physiol Lung Cell Mol Physiol 294:L797-L806 (Pubitemid 351520114)
13. Jernigan NL, Walker BR, Resta TC (2008) Reactive oxygen species mediate RhoA/Rho kinase-induced Ca2+ sensitization in pulmonary vascular smooth muscle following chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 295:L515-L529
14. Weigand L, Sylvester JT, Shimoda LA (2006) Mechanisms of endothelin-1-induced contraction in pulmonary arteries from chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 290:L284-L290
15. Wang J, Weigand L, Foxson J, Shimoda LA, Sylvester JT (2007) Ca2+ signaling in hypoxic pulmonary vasoconstriction: effects of myosin light chain and rho kinase antagonists. Am J Physiol Lung Cell Mol Physiol 293:L674-L685 (Pubitemid 47358830)
16. Badejo AM Jr, Dhaliwal JS, Casey DB, Gallen TB, Greco AJ, Kadowitz PJ (2008) Analysis of pulmonary vasodilator responses to the Rho-kinase inhibitor fasudil in the anesthetized rat. Am J Physiol Lung Cell Mol Physiol 295:L828-L836
17. Fagan KA, Oka M, Bauer NR et al (2004) Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287:L656-L664 (Pubitemid 39249378)
18. Nagaoka T, Morio Y, Casanova N et al (2004) Rho/Rho kinase signaling mediates increased basal pulmonary vascular tone in chronically hypoxic rats. Am J Physiol Lung Cell Mol Physiol 287:L665-L672 (Pubitemid 39249379)
19. Robertson TP, Dipp M, Ward JPT, Aaronson PI, Evans AM (2000) Inhibition of sustained hypoxic vasoconstriction by Y-27632 in isolated intrapulmonary arteries and perfused lung of the rat. Br J Pharmacol 131:5-9
20. Knock GA, Snetkov VA, Shaifta Y et al (2009) Superoxide constricts rat pulmonary arteries via Rho-kinase-mediated Ca2+ sensitization. Free Radic Biol Med 46:633-642
21. Homma N, Nagaoka T, Morio Y et al (2007) Endothelin-1 and serotonin are involved in activation of RhoA/Rho kinase signaling in the chronically hypoxic hypertensive rat pulmonary circulation. J Cardiovasc Pharmacol 50:697-702 (Pubitemid 350307041)
22. Barman SA (2007) Vasoconstrictor effect of endothelin-1 on hypertensive pulmonary arterial smooth muscle involves Rho-kinase and protein kinase C. Am J Physiol Lung Cell Mol Physiol 293:L472-L479 (Pubitemid 47205028)
23. Alapati VR, McKenzie C, Blair A, Kenny D, MacDonald A, Shaw AM (2007) Mechanisms of U46619- and 5-HT-induced contraction of bovine pulmonary arteries: role of chloride ions. Br J Pharmacol 151:1224-1234 (Pubitemid 47255905)
24. Janssen LJ, Premji M, Netherton S, Coruzzi J, Lu-Chao H, Cox PG (2001) Vasoconstrictor actions of isoprostanes via tyrosine kinase and Rho kinase in human and canine pulmonary vascular smooth muscles. Br J Pharmacol 132:127-134 (Pubitemid 32128441)
25. Martin C, Goggel R, Ressmeyer AR, Uhlig S (2004) Pressor responses to platelet-activating factor and thromboxane are mediated by Rho-kinase. Am J Physiol Lung Cell Mol Physiol 287:L250-L257 (Pubitemid 38796445)
26. Knock GA, Shaifta Y, Snetkov VA et al (2008) Interaction between src family kinases and Rhokinase in agonist-induced Ca2+-sensitization of rat pulmonary artery. Cardiovasc Res 77:570-579 (Pubitemid 351197665)
27. Rodat-Despoix L, Crevel H, Marthan R, Savineau JP, Guibert C (2008) Heterogeneity in 5-HT-induced contractile and proliferative responses in rat pulmonary arterial bed. J Vasc Res 45:181-192 (Pubitemid 351543142)
28. Witzenrath M, Ahrens B, Kube SM et al (2006) Allergic lung inflammation induces pulmonary vascular hyperresponsiveness. Eur Respir J 28:370-377 (Pubitemid 44914238)
29. Boer C, van der Linden PJ, Scheffer GJ, Westerhof N, de Lange JJ, Sipkema P (2002) RhoA/ Rho kinase and nitric oxide modulate the agonist-induced pulmonary artery diameter response time. Am J Physiol Heart Circ Physiol 282:H990-H998 (Pubitemid 34654938)
30. Damron DS, Kanaya N, Homma Y, Kim SO, Murray PA (2002) Role of PKC, tyrosine kinases, and Rho kinase in a-adrenoreceptor-mediated PASM contraction. Am J Physiol Lung Cell Mol Physiol 283:L1051-L1064 (Pubitemid 35204897)
31. Losapio JL, Sprague RS, Lonigro AJ, Stephenson AH (2005) 5,6-EET-induced contraction of intralobar pulmonary arteries depends on the activation of Rho-kinase. J Appl Physiol 99:1391-1396 (Pubitemid 43014345)
32. Thomas GD, Snetkov VA, Patel R, Leach RM, Aaronson PI, Ward JPT (2005) Sphingosylphosphorylcholine-induced vasoconstriction of pulmonary artery: activation of nonstore- operated Ca2+ entry. Cardiovasc Res 68:56-64 (Pubitemid 41253556)
33. Beutz MA, Nagaoka T, Oka M, McMurtry IF (2005) Sphingosine-1-phosphate constricts fawn-hooded rat pulmonary arteries. Proc Am Thorac Soc 2:A706
34. Hyvelin JM, Howell K, Nichol A, Costello CM, Preston RJ, McLoughlin P (2005) Inhibition of Rho-kinase attenuates hypoxia-induced angiogenesis in the pulmonary circulation. Circ Res 97:185-191 (Pubitemid 41033475)
35. McNamara PJ, Murthy P, Kantores C et al (2008) Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide. Am J Physiol Lung Cell Mol Physiol 294:L205-L213 (Pubitemid 351253358)
36. Stenmark KR, McMurtry IF (2005) Vascular remodeling versus vasoconstriction in chronic hypoxic pulmonary hypertension: a time for reappraisal? Circ Res 97:95-98 (Pubitemid 41033463)
37. Howell K, Preston RJ, McLoughlin P (2003) Chronic hypoxia causes angiogenesis in addition to remodelling in the adult rat pulmonary circulation. J Physiol 547:133-145 (Pubitemid 36285169)
38. van Suylen RJ, Smits JF, Daemen MJ (1998) Pulmonary artery remodeling differs in hypoxia- and monocrotaline-induced pulmonary hypertension. Am J Respir Crit Care Med 157:1423-1428
39. Crossno JT Jr, Garat CV, Reusch JE et al (2007) Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling. Am J Physiol Lung Cell Mol Physiol 292:L885-L897 (Pubitemid 46608235)
40. Daley E, Emson C, Guignabert C et al (2008) Pulmonary arterial remodeling induced by a Th2 immune response. J Exp Med 205:361-372 (Pubitemid 351281602)
41. Hopkins N, Cadogan E, Giles S, McLoughlin P (2001) Chronic airway infection leads to angiogenesis in the pulmonary circulation. J Appl Physiol 91:919-928 (Pubitemid 32681128)
42. Nagaoka T, Fagan KA, Gebb SA et al (2005) Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension. Am J Respir Crit Care Med 171:494-499 (Pubitemid 40444250)
43. Homma N, Nagaoka T, Karoor V et al (2008) Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. Am J Physiol Lung Cell Mol Physiol 295:L71-L78
44. Oka M, Homma N, Taraseviciene-Stewart L et al (2007) Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats. Circ Res 100:923-929 (Pubitemid 46555698)
45. Nagaoka T, Gebb SA, Karoor V et al (2006) Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hooded rat. J Appl Physiol 100:996-1002 (Pubitemid 43671557)
46. Jiang BH, Tawara S, Abe K, Takaki A, Fukumoto Y, Shimokawa H (2007) Acute vasodilator effect of fasudil, a Rho-kinase inhibitor, in monocrotaline-induced pulmonary hypertension in rats. J Cardiovasc Pharmacol 49:85-89
47. Parker TA, Roe G, Grover TR, Abman SH (2006) Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lung. Am J Physiol Lung Cell Mol Physiol 291:L976-L982 (Pubitemid 44772060)
48. Young KA, Ivester C, West J, Carr M, Rodman DM (2006) BMP signaling controls PASMC Kv channel expression in vitro and in vivo. Am J Physiol Lung Cell Mol Physiol 290:L841-L848 (Pubitemid 43725045)
49. Long L, MacLean MR, Jeffery TK et al (2006) Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 98:818-827
50. Frank DB, Lowery J, Anderson L, Brink M, Reese J, de Caestecker M (2008) Increased susceptibility to hypoxic pulmonary hypertension in bmpr2 mutant mice is associated with endothelial dysfunction in the pulmonary vasculature. Am J Physiol Lung Cell Mol Physiol 294:L98-L109 (Pubitemid 351380322)
51. Song Y, Coleman L, Shi J et al (2008) Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice. Am J Physiol Heart Circ Physiol 295:H677-H690
52. Doe Z, Fukumoto Y, Takaki A et al (2008) Evidence for Rho-kinase activation in patients with pulmonary hypertension. Circulation 118:S-446
53. Guilluy C, Eddahibi S, Agard C et al (2009) Rhoa and Rho kinase activation in human pulmonary hypertension - role of 5-HT signaling. Am J Respir Crit Care Med 179(12):1151-1158
54. Hemnes AR, Wigley F, Rodrigues FW, Girgis RE, Yang SC, Conte JV (2005) Pulmonary hypertension is associated with increased expression and activity of phosphodiesterase type 5a. Circulation 112:II-221-II-222
55. Laumanns IP, Fink L, Wilhelm J et al (2009) The non-canonical WNT-pathway is operative in idiopathic pulmonary arterial hypertension. Am J Respir Cell Mol Biol 40(6):683-691
56. Fukumoto Y, Matoba T, Ito A et al (2005) Acute vasodilator effects of a Rho-kinase inhibitor, fasudil, in patients with severe pulmonary hypertension. Heart 91:391-392 (Pubitemid 40299237)
57. Ishikura K, Yamada N, Ito M et al (2006) Beneficial acute effects of Rho-kinase inhibitor in patients with pulmonary arterial hypertension. Circ J 70:174-178 (Pubitemid 43170128)
58. Li F, Xia W, Yuan S, Sun R (2009) Acute inhibition of Rho-kinase attenuates pulmonary hypertension in patients with congenital heart disease. Pediatr Cardiol 30(3):363-366
59. Schermuly RT, Dony E, Ghofrani HA et al (2005) Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115:2811-2821 (Pubitemid 41434408)
60. Gokina NI, Park KM, McElroy-Yaggy K, Osol G (2005) Effects of Rho kinase inhibition on cerebral artery myogenic tone and reactivity. J Appl Physiol 98:1940-1948 (Pubitemid 40570810)